P.A.W. Capital’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
P.A.W. Capital's GILD Position: Q4 2017 in Review
P.A.W. Capital sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 15,000 shares — an estimated $1.22M sold.
P.A.W. Capital first reported a position in GILD in Q2 2014 and held it in 14 quarters. The position peaked at $2.12M in Q2 2017. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.
- P.A.W. Capital reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
- P.A.W. Capital sold 15,000 Gilead Sciences shares in Q4 2017, an estimated $1.22M.
- P.A.W. Capital first reported a position in Gilead Sciences in Q2 2014 and held it in 14 quarters.
- P.A.W. Capital's Gilead Sciences position peaked at $2.12M in Q2 2017.
- 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.
Based on P.A.W. Capital's 13F filing for Q4 2017, filed 31 Jan 2018.